Shionogi & Co.,Ltd.

4507

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-03FY2027 Q1

Revenue

5632.1100M JPY

YoY +27.9%

Operating Income

669.1100M JPY

YoY +90.6%

Net Income

2635100M JPY

YoY +47.1%

EPS

114.8JPY

YoY +148.2%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

4996.8億円

3747.6億円

2498.4億円

1249.2億円

Rev: 3351.4億円Op: 1103.1億円NI: 1141.8億円

Rev: 4266.8億円Op: 1490億円NI: 1849.7億円

Rev: 4350.8億円Op: 1533.1億円NI: 1620.3億円

Rev: 4382.7億円Op: 1566億円NI: 1704.3億円

Rev: 4996.8億円Op: 1667.3億円NI: 2051.6億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income46.5%

Revenue Progress1633.100M

Revenue Forecast700000M

Net Income Progress97700M

Net Income Forecast210000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan